Logo image
Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles
Journal article   Open access   Peer reviewed

Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles

Ekaterina V Fedorova, Sheree M Schrager, Lucy F Robinson, Alice Cepeda, Carolyn F Wong, Ellen Iverson and Stephen E Lankenau
Drug and alcohol dependence, v 198, pp 21-27
01 May 2019
PMID: 30861391
url
https://europepmc.org/articles/pmc7336713View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Prescription drug misuse Young adults Medical marijuana Dabbing Medical Cannabis Edibles Drug use
•Medical cannabis patient status was not associated with use of other drugs.•Self-reported medical cannabis use was negatively associated with illicit drug use.•Solitary cannabis users were less likely to misuse prescription drugs.•Alternative cannabis forms use was associated use of other drugs. Young adults have the highest rates of cannabis and other drug use, as compared to other age groups, and contribute a significant proportion to the total population of medical cannabis patients (MCP). However, little is known about the relationships between various cannabis practices and illicit drug use/prescription drug misuse among young adult cannabis users with and without legal access to medical cannabis. 210 MCP and 156 non-patient cannabis users (NPU) aged 18–26 were recruited in Los Angeles in 2014–15 for a longitudinal study assessing the impact of medical cannabis on health and substance use among emerging adults. For the present analysis, only quantitative baseline survey data were used. Logistic regression was used to examine the associations between past 90-day cannabis practices and other drug use, including illicit drug use and prescription drug misuse. Illicit drug use was associated with being non-Hispanic white (AOR = 3.0, 95% CI 1.8–5.1), use of cannabis concentrates (AOR = 2.8, 95% CI 1.6–4.9), while self-reported medical cannabis use was associated with lower probability of illicit drug use (AOR = 0.5, 95% CI 0.3–0.9). The odds of prescription drug misuse were increased for participants who reported use of cannabis edibles (AOR = 2.0, 95% CI 1.1–3.5), and decreased with age (AOR = 0.9, 95% CI 0.8–1.0) and for those who used cannabis alone (AOR = 0.5, 95% CI 0.3–0.9). Use of alternative cannabis forms, but not cannabis use frequency, were associated with greater odds of other drug use. Self-reported medical cannabis use, but not MCP status, decreased probability of illicit drug use.

Metrics

10 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Psychiatry
Substance Abuse
Logo image